ANTISENSE-MEDIATED REDUCTION IN INSULIN-LIKE GROWTH-FACTOR-I RECEPTOREXPRESSION SUPPRESSES THE MALIGNANT PHENOTYPE OF A HUMAN ALVEOLAR RHABDOMYOSARCOMA
Dn. Shapiro et al., ANTISENSE-MEDIATED REDUCTION IN INSULIN-LIKE GROWTH-FACTOR-I RECEPTOREXPRESSION SUPPRESSES THE MALIGNANT PHENOTYPE OF A HUMAN ALVEOLAR RHABDOMYOSARCOMA, The Journal of clinical investigation, 94(3), 1994, pp. 1235-1242
The expression of the insulin-like growth factors (IGFs) and their rec
eptors has been linked to cellular proliferation and tumorigenicity in
a number of model systems. Since rhabdomyosarcoma cells express IGF-I
receptors, an autocrine or paracrine loop involving this receptor and
its ligands could be responsible in part for the growth characteristi
cs of this tumor. To assess directly the role of the IGF-I receptor in
rhabdomyosarcoma cell growth and tumorigenicity, a human alveolar rha
bdomyosarcoma cell line with high IGF-I receptor expression was transf
ected with an amplifiable IGF-I receptor antisense expression vector.
Four unique, transfected clones were analyzed and found to have reduce
d IGF-I receptor expression relative to the parental line. Integration
of the antisense sequence was demonstrated by Southern blot analysis,
and expression of antisense message in these clones was shown by S1 n
uclease protection assay. Reduced IGF-I receptor surface expression in
the transfectants was shown by decreased immunofluorescence with an I
GF-I receptor monoclonal antibody and by decreased IGF-I binding as me
asured by Scatchard analysis. These clones had markedly reduced growth
rates in vitro, impaired colony formation in soft agar, and failed to
form tumors in immunodeficient mice when compared with vector-transfe
cted clones. These results demonstrate that reduction of IGF-I recepto
r expression can inhibit both the in vitro and in vivo growth of a hum
an rhabdomyosarcoma cell line and suggest a role for the IGF-I recepto
r in mediating neoplastic growth in this mesenchymally derived tumor.